Semaglutide + Cagrilintide
Weight Loss (GLP-1)Known as CagriSema, this combination pairs a GLP-1 agonist with an amylin analog for enhanced weight loss. Currently in clinical trials by Novo Nordisk.
Vendors tracked
Coming soon
Compare Prices
No vendor data yet
We're actively adding vendors and pricing for this peptide. Our scrapers run daily — check back soon for live comparison data.
Get Semaglutide + Cagrilintide price alerts
We'll email you when prices drop or new vendors are added.